NCT00222092View on ClinicalTrials.gov

Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers

CompletedOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2006

Conditions

Post-ERCP Acute Pancreatitis

Trial Locations (1)

45110

Hepato-Gastroenterology Unit, Medical School of Ioannina - Greece, Ioannina

All Listed Sponsors

lead

University of Ioannina

OTHER

NCT00222092 - Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers | Biotech Hunter | Biotech Hunter